I think they definitely could be working on other products. Because it comes down to matching up the correct amount of Naltrexone to counter act the Opioid, the idea is pretty simple.
The ANDA part of it could be to make a generic Embeda which what Watson did. And there may be other options based on type of approvals Elite is pursuing. Lasers probably can explain this much better since he is in the field.
That's why the whole argument about ALO-02 is so entertaining to me. Even if Pfeizer gets these products to market which as of right now looks to be a few years away, Elite can make generics of all of them.
News 
Market Data 
Discover 
